Subject Index
Coagulation Factors and Inhibitors
Fibrinolysis, fibrinogen, fibrin
Haemorrhagic Disorders
Invited
Other
Platelets
Thrombotic Disorders and antithrombotic therapy
Vascular Biology
Haemorrhagic Disorders
Acquired coagulation disorders (including DIC)
Gene therapy
Haemophilia A and B
Haemophilia: therapy
Haemostatic agents
Immunology (including ITP and HIT)
Inherited coagulation disorders
Other haemmorrhagic disorders
Perinatal/pediatric haemostatis
Transfusion and storage
von Willebrand disease
von Willebrand factor
Determination of overall hemostasis potential in different coagulation factors deficient plasma and in plasma samples from patients with hemophilia A and B
Antovic A., Petrini P., Blombäck M., He S.
Early FVIII Exposure and Subsequent Inhibitor Development in Children with Severe Haemophilia A
Chalmers EA, Williams MD, Richards M, Brown SA, Liesner R, Thomas A, Vidler V, Keeling D, Smith D, Hill FGH
Hemophilia B Mice Have Delayed Wound Healing
Meng ZH, Lenkowski A, Hoffman M, Hedner U, Roberts HR, Monroe DM
Prophylaxis with Factor VIII Protects Children with Hemophilia a from Inhibitor Development
Santagostino E, Mancuso ME, Rocino A, Mazzucconi MG, Mancuso G, Tagliaferri A, Messina M, Luciani M, Boeri E, Mannucci PM
Successful Diagnosis in Pregnant Obligate Carriers of Hemophilia a of Fetal Sex Using Conventional Pcr Analysis of Maternal Plasma
Colaizzo D, Tiscia T, Foti L, Vergura P, Sonni P, Cappucci F, Grandone E, Toni D, Margaglione M, Vecchione G, Chinni E, Santacroce R, Tomaiuolo M, Sessa F, Sarno M, Grandone E, Di Minno G, Margaglione M
The Time Courses of Fibrin Formation, Prothrombin Activation and TAFI Activation in Normal and Factor VIII-Deficient Plasma
Foley JH, Kim PY, Yu AYH, Ward VA, Nesheim ME